AstraZeneca PLC header image

AstraZeneca PLC

AZN

Equity

ISIN GB0009895292 / Valor 982352

LSE London Stock Exchange, SETS (2025-11-20)

GBP 136.50+0.40%

AstraZeneca PLC
UMushroom community rating:

4.03 20 votes No rating yet

NegativeNeutralPositive

About company

AstraZeneca PLC is a global pharmaceutical company with a focus on the discovery, development, and commercialization of prescription medicines across various therapy areas. The company is science-led and patient-focused, aiming to address unmet medical needs by bringing innovative medicines to market. AstraZeneca operates in key therapeutic areas including Oncology, Cardiovascular, Renal & Metabolism, and Respiratory & Immunology, with a growing pipeline in rare diseases. Its business strategy emphasizes growth through innovation, leveraging advanced therapeutic modalities and engaging in strategic partnerships to enhance healthcare outcomes. AstraZeneca's commitment to healthcare extends to improving access to its medicines globally, ensuring it plays a significant role in transforming the future of healthcare.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

36.9%1Y

25.0%3Y

64.2%5Y

Performance

28.2%1Y

23.8%3Y

23.9%5Y

Volatility

276436 M

Market cap (USD)

1,177,749

Daily traded volume (Shares)

104.82 / 103.6

1 day high/low (USD)

0.00 / 0.00

52 weeks high/low (USD)

01 January, 2022

Dividend ex-date

0.00

Dividend (USD)

0.00%

Dividend yield (p.a.)

0.002022

0.002023

0.002024

Est dividend (USD)

0.00%2022

0.00%2023

0.00%2024

Est dividend yield

10.00

P/E ratio

00.002022

00.002023

00.002024

Est P/E ratio

0.00

EPS (USD)

0.002022

0.002023

0.002024

Est EPS (USD)

Ratings & reviews

4.03

20 votes

Performance:

3.62

Innovation:

4.25

Society:

3.73

Nature:

3.42

Aran Grant

United Kingdom, 09 Nov 2025

Health stocks nice and stable

Deny Purwanto

United Kingdom, 09 Nov 2025

.

Korbinian Kramer

United Kingdom, 08 Nov 2025

Strong growth due to the comapnies strength in innovation and high drug demand

EQUITIES OF THE SAME SECTOR

Dermapharm Holding SE

Dermapharm Holding SE Valor: 40166352

Annual Return

-50%0%+50%

Risk level

110

0.42%EUR 35.45

Straumann Holding Ltd

Straumann Holding Ltd Valor: 117544866

Annual Return

-50%0%+50%

Risk level

110

-0.60%CHF 95.34

Tecan Group Ltd.

Tecan Group Ltd. Valor: 1210019

Annual Return

-50%0%+50%

Risk level

110

-0.30%CHF 133.00

Siegfried Holding Ltd

Siegfried Holding Ltd Valor: 1428449

Annual Return

-50%0%+50%

Risk level

110

1.59%CHF 70.10

COSMO Pharmaceuticals N.V.

COSMO Pharmaceuticals N.V. Valor: 32590356

Annual Return

-50%0%+50%

Risk level

110

1.97%CHF 67.40

medmix Ltd

medmix Ltd Valor: 112967710

Annual Return

-50%0%+50%

Risk level

110

-0.83%CHF 8.34

SHL Telemedicine Ltd

SHL Telemedicine Ltd Valor: 1128957

Annual Return

-50%0%+50%

Risk level

110

11.57%CHF 1.35

Fagron SA

Fagron SA Valor: 3425437

Annual Return

-50%0%+50%

Risk level

110

0.74%EUR 20.50

Coloplast A/S

Coloplast A/S Valor: 20259063

Annual Return

-50%0%+50%

Risk level

110

1.12%DKK 577.00

Ardent Health Partners Inc

Ardent Health Partners Inc Valor: 136301364

Annual Return

-50%0%+50%

Risk level

110

0.12%USD 8.64

SIX

FactSet

Clearbit

Logos provided by Clearbit